Among the companies with shares expected to actively trade in Tuesday’s session are Forest Laboratories Inc.(FRX), Coca-Cola Co.(KO) and Waste Management Inc.(WM)
Actavis(ACT) PLC confirmed plans to acquire rival drug maker Forest Labs in a cash-and-stock deal that values Forest at about $25 billion. Shares of Forest Labs rose 30% to $93.06 premarket. Actavis shares rose 8.2% to $207.70.
Coca-Cola said it is looking for ways to “restore momentum” as it posted lower fourth-quarter results that concluded a challenging year for the soft-drink giant. Coke’s revenue for the quarter missed Wall Street expectations, while profit declined. Shares dropped 1.6% to $38.32 premarket.
Waste Management swung to a fourth-quarter loss as the waste-disposal company posted high asset impairment charges and reported higher accruals from incentive compensation. Adjusted bottom-line results missed estimates, and the company offered a disappointing earnings outlook for 2014. Shares dropped 3.4% to $42.20 premarket.
Navidea Biopharmaceuticals Inc.(NAVB) said the U.S. Food and Drug Administration has granted a priority review for an expanded use of its Lymphoseek drug for some patients with head and neck cancer. Shares dropped 5.4% to $1.97 premarket.
Prana Biotechnology Ltd.(PBT.AU) said its experimental treatment for Huntington disease met its primary goals of safety as well as significant improvement in cognitive function in a Phase II study. Shares rose 17% to $8.45 in recent premarket trading.
Ameren Corp.(AEE) named Warner L. Baxter as its new chief executive, replacing Thomas R. Voss, who is retiring from the utility operator. Mr. Baxter will take on the new position on April 24, at which time Mr. Voss will become executive chairman.
Duke Energy Corp.(DUK) said its fourth-quarter earnings rose a bigger-than-expected 58%, helped by strength in its regulated utilities and international businesses.
Fresh Del Monte Produce Inc.(FDP) said sales rose in the fourth quarter, driven by a surge in its banana business. The company, however, posted a wider net loss due to higher impairment charges and costs.
Medtronic Inc.(MDT) said its fiscal third-quarter earnings fell 23% on a big write-down related to the medical-device maker’s renal denervation program that masked revenue growth. The company narrowed its earnings forecast for the year.
Rothesay Life Ltd. agreed to buy MetLife Inc.'s(MET) U.K.-based annuity pension unit as it continues to build out its annuity portfolio. Financial terms of the deal, which is expected to close in the second quarter, weren’t disclosed.
NiSource Inc.(NI) said its fourth-quarter profit rose 13% as all three of the utility company’s segments posted revenue growth. But the top line missed estimates.
Stryker Corp.(SYK) agreed to acquire privately held surgical-equipment company Berchtold Holding AG for an enterprise value of $172 million. Berchtold, which has operations in Germany and the U.S., generated sales of roughly $125 million last year. The company’s products include surgical tables, equipment booms and surgical lighting systems.